Sky Century Investment (SKYI) Change in Accured Expenses (2012 - 2026)
Sky Century Investment (SKYI) reported Change in Accured Expenses of -$7443.0 for Q1 2026, up 64.23% year-over-year from -$4532.1 in Q1 2025, and down 179.64% quarter-over-quarter from $9346.0 in Q4 2025.
Sky Century Investment (SKYI) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 6 years of Change in Accured Expenses data on file, last reported at -$7443.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$7443.0, up 64.23% year-over-year; the trailing twelve-month figure through Feb 2026 was $60697.0 (up 26.45% YoY), and the FY2025 annual result was $59897.0, down 25.03% from the prior year.
- Change in Accured Expenses slipped to -$7443.0 in Q1 2026 per SKYI's latest filing, from $9346.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $61847.0 in Q2 2025 and troughed at -$20807.0 in Q1 2025.
- A 3-year average of $14807.4 and a median of $9346.0 in 2025 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 1961.57% in 2025 and fell as far as 184.68% in 2025.
- A 3-year view of Change in Accured Expenses shows it stood at $21910.0 in 2024, then sank by 57.34% to $9346.0 in 2025, then tumbled by 179.64% to -$7443.0 in 2026.
- Business Quant data shows SKYI's Change in Accured Expenses at -$7443.0 in Q1 2026, $9346.0 in Q4 2025, and -$3053.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Sky Century Investment | - | - | 31,666.00 | -7,443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,443.00 |
| Feb 28, 2026 | -7,443.00 |
| Nov 30, 2025 | 9,346.00 |
| Nov 30, 2025 | 9,346.00 |
| Aug 31, 2025 | -3,053.00 |
| Aug 31, 2025 | -3,053.00 |
| May 31, 2025 | 61,847.00 |
| May 31, 2025 | 61,847.00 |
| Feb 28, 2025 | -20,807.00 |
| Feb 28, 2025 | -20,807.00 |
| Nov 30, 2024 | 21,910.00 |
| Nov 30, 2024 | 21,910.00 |
| Aug 31, 2024 | 43,897.00 |
| Aug 31, 2024 | 43,897.00 |
| May 31, 2024 | 3,000.00 |
| May 31, 2024 | 3,000.00 |
| Feb 29, 2024 | 24,570.00 |
| Feb 29, 2024 | 24,570.00 |
| Aug 31, 2014 | 8,430.00 |
| Aug 31, 2014 | 8,430.00 |